MicroBiome develops and commercializes novel non-prescription therapies for the treatment of metabolic diseases... Read more
MicroBiome develops and commercializes novel non-prescription therapies for the treatment of metabolic diseases... Read more
News
Jul 16, 2019
PR Newswire
Press Release: MBT : Seed Health Joins Microbiome Therapeutics Innovation Group
Oct 01, 2018
Pharamceutical Technology
MBT: Regulatory and IP strategies for live biotherapeutic products
Oct 01, 2018
Pharamceutical Technology
MBT: From Parkinson's to asthma: opportunities for microbiome-based therapeutics
Nov 06, 2017
NutraIngredients-USA
Microbiome Therapeutics: Microbiome Therapeutics prepares to launch 'microbiome modulator'
Nov 02, 2017
FinSMEs
Microbiome Therapeutics: MicroBiome Therapeutics Completes $1M Series B Financing
Dec 22, 2016
Blackbird
Press Release: Microbiome Therapeutics : Microbiome Therapeutics Market By Type, Application, Region & Segment Forecasts, 2014 - 2025 - Research and Markets
Nov 08, 2016
BioSpace
Microbiome Therapeutics: MicroBiome Therapeutics LLC, Hidden Chemical Secrets, Being Accessed At Scripps Pier In San Diego
Oct 13, 2016
NutraIngredients-USA
Microbiome Therapeutics: Blood glucose supplement developer files for patent on formulation
Oct 11, 2016
BioSpace
Microbiome Therapeutics: MicroBiome Therapeutics LLC' Nm504 For Improving Blood Glucose Regulation Is First Microbiome Modulator To Receive U.S. Patent Allowance
Aug 15, 2016
BioSpace
Microbiome Therapeutics: Vedanta Biosciences Granted U.S. Patent Broadly Covering Pharmaceutical Compositions For Microbiome Therapeutics Based On Bacterial Consortia
MicroBiome Therapeutics, LLC Competitors
1
2
3
4
5
6
7
8
9
10